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A Call to IndustryShalom Jacobovitz, Chief Executive Ofﬁcer, American College of CardiologyT obacco use is the common denominator in40% of all cardiovascular disease cases (1)and accounts for 480,000 deaths each year
as the leading cause of preventable death in the United
States (2). Not surprisingly, the life expectancy of
smokers is 10 years shorter than for nonsmokers (3).
However, even nonusers are affected. Secondhand
smoke, which contains a mixture of 7,000 chemicals,
causes nearly 34,000 deaths annually from heart dis-
ease (4). As leaders in the health care industry, we are
acutely aware of these alarming statistics and are call-
ing on our colleagues and partners in our ﬁeld to stand
together and put an end to tobacco use in America.
Efforts to end tobacco use in America have
certainly made strides in the last 5 decades, as the
percentage of American adults that smoke has
dropped by 57% (from 42% in 1964 to 18% today)
since the 1960s, when the Surgeon General ﬁrst is-
sued a warning about cigarette use and the Federal
Trade Commission mandated prominent warnings on
cigarette packages and cigarette advertisements (1).
At the state level, legislation has helped play into
this decline as a growing number of states have
implemented 100% smoke-free laws in nonhospitality
workplaces, restaurants, and bars, and many others
have smoke-free legislation pending or partial smoke-
free laws already in place. There are only a handful of
states that have not engaged in state-wide smoke-free
legislation—Alabama, Alaska, Kentucky, Mississippi,
Missouri, Oklahoma, South Carolina, Texas, West
Virginia, and Wyoming—and we look to them to take a
stand as well. Additionally, the American College of
Cardiology (ACC) just this year has worked closely
with the Campaign for Tobacco Free Kids to urge the
Food and Drug Administration to further regulate
tobacco products, including e-cigarettes.Cardiology, Washington, DC.Unfortunately, despite increased taxation on
tobacco products and smoke-free legislation, ciga-
rettes are still used by more than 42 million adult
Americans (2), and the burden on health care systems
is heavy. Annual smoking-attributable economic costs
in the United States between just 2009 and 2012
reached more than $289 billion (4). This year, on the
50th anniversary of a Surgeon General’s report
commissioned by then President John F. Kennedy, the
Ofﬁce of the Surgeon General released a report high-
lighting a number of obstacles still plaguing public
health, including the burden of death and disease from
tobacco use. The report states that rapid elimination of
tobacco use will dramatically reduce this burden (4).
CVS Health is boldly answering this call by pulling
tobacco products off its shelves (5). As of October 1,
2014, all 7,600 CVS pharmacy stores across the United
States are no longer selling tobacco products. In
addition, the company has created a national onsite
and digital comprehensive smoking cessation pro-
gram as part of its commitment to putting cus-
tomers on the path to better health. This shows the
commitment that CVS Health has made to put the
health of its customers above the proﬁts of the orga-
nization. We hope this inspires other major retail
pharmacies like Walgreens, Walmart, Rite Aid, and
others to hopefully follow that philosophy.
If we are serious about improving public health and
reducing the skyrocketing health care costs associ-
ated with treatment of chronic disease, it is important
that we get behind companies like CVS Health and
work together in ways we have not before.
As part of its 5-year strategic plan centered on the
“triple aim” of better care, better outcomes, and
lower cost, the ACC is committed to public health and
improving the health of populations. The College is
committed to developing partnerships with organi-
zations and other stakeholder groups, like CVS
Health, to pursue national and international popula-
tion health objectives related to cardiovascular
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2702disease health. The ACC is also supporting its mem-
bers in their expanded accountability to improve the
health of populations and encouraging cardiovascular
team-facilitated patient education on topics like
smoking cessation.
Focusing on prevention is a key component of the
ACC’s commitment to population health, and the
College is doing so by arming cardiovascular pro-
fessionals with point-of-care tools and resources to
share with their patients—particularly via ACC’s
CardioSmart program. The College’s Prevention
Committee is ACC’s direct member connection to
programming and resources surrounding the pre-
vention of cardiovascular disease, and is a key player
in driving the College’s strategies. The ACC’s part-
nership with the Million Hearts initiative, which has
set out to prevent 1 million cardiovascular events
by 2017, is focused on improving management of
4 cardiovascular disease indicators, 1 of which is
smoking cessation. Additionally, the ACC is part of
the Non-Communicable Diseases (NCD) Alliance, a
global task force that emerged in response to a
May 2012 declaration by the United Nations to reducepremature death caused by noncommunicable dis-
eases by 25% by the year 2025. The NCD Alliance has
established risk factor reduction targets, including a
30% relative reduction in the prevalence of tobacco
smoking (6).
Partnerships are key as we work to tackle the
lingering tobacco use problem in America. Pharma-
cies should join CVS Health in pulling tobacco prod-
ucts from their shelves. The ACC welcomes the
continued or expanded partnership with like-minded
health care organizations who continue to advocate
for tobacco-free legislation, help arm cardiovascular
professionals with tools to talk with their patients
about tobacco use, and direct tools and resources for
patients around prevention or how to quit. Together,
we can make tobacco use an anachronism. We look
forward to the day when cardiovascular mortality
and tobacco use no longer correlate at such a high rate
in America.
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